1.0Reproductive Health Access Projecthttps://www.reproductiveaccess.orgSilpa Srinivasuluhttps://www.reproductiveaccess.org/author/silpa/Clinicians' Perspectives on Mifepristone Regulations in Primary Care - Reproductive Health Access Projectrich600338<blockquote class="wp-embedded-content" data-secret="kQOLyjywtJ"><a href="https://www.reproductiveaccess.org/resource/clinicians-perspectives-on-mifepristone-regulations-in-primary-care/">Clinicians’ Perspectives on Mifepristone Regulations in Primary Care</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.reproductiveaccess.org/resource/clinicians-perspectives-on-mifepristone-regulations-in-primary-care/embed/#?secret=kQOLyjywtJ" width="600" height="338" title="“Clinicians’ Perspectives on Mifepristone Regulations in Primary Care” — Reproductive Health Access Project" data-secret="kQOLyjywtJ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
https://www.reproductiveaccess.org/wp-content/uploads/2021/05/mife-storytelling_JPEG_sm.jpeg85115This publication details an exploratory study of US primary care clinicians’ perspectives on the effects of mifepristone restrictions, including US Food and Drug Administration (FDA) regulations, on access to medication abortion and early pregnancy loss (EPL) management in primary care. Protocols including mifepristone are the most effective medication regimens for medication abortion and EPL management.…